Medpace Holdings (MEDP) Current Deferred Revenue (2015 - 2026)

Medpace Holdings (MEDP) has 12 years of Current Deferred Revenue data on file, last reported at $904.7 million in Q2 2026.

• Quarterly Current Deferred Revenue rose 11.86% year-over-year to $904.7 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $904.7 million (up 11.86% YoY) and the FY2025 annual result came in at $854.4 million, up 20.24% from the prior year.
• Current Deferred Revenue rose to $904.7 million in Q2 2026, from $856.3 million in the prior quarter.
• In the past five years, Current Deferred Revenue ranged from a high of $904.7 million in Q2 2026 to a low of $367.2 million in Q1 2022.
• A 5-year average of $627.7 million and a median of $627.6 million in 2024 frame the typical range for Current Deferred Revenue.
• Annual changes were most pronounced in 2022 — Current Deferred Revenue soared 42.22% — and 2026, when it increased 11.86%.
• Tracing MEDP's Current Deferred Revenue over 5 years: stood at $462.7 million in 2022, then rose by 20.99% to $559.9 million in 2023, then rose by 26.92% to $710.6 million in 2024, then gained by 20.24% to $854.4 million in 2025, then climbed by 5.89% to $904.7 million in 2026.
• The last three Current Deferred Revenue figures came in at $904.7 million (Q2 2026), $856.3 million (Q1 2026), and $854.4 million (Q4 2025), per Business Quant data.